Literature DB >> 22951901

Cyclic AMP, protein kinase A, and phosphodiesterases: proceedings of an international workshop.

C A Stratakis.   

Abstract

Cyclic nucleotides cAMP and cGMP are part of almost all major cellular signaling pathways. Phosphodiesterases (PDEs) are enzymes that regulate the intracellular levels of cAMP and cGMP. Protein kinase A or cAMP-dependent protein kinase mediates most cAMP effects in the cell. Over the last 25 years, various components of this group of molecules have been involved in human diseases, both genetic and acquired. Lately, the PDEs attract more attention. The pharmacological exploitation of the PDE's ability to regulate cGMP and cAMP, and through them, a variety of signaling pathways, has led to a number of new drugs for diverse applications from the treatment of erectile dysfunction to heart failure, asthma, and chronic obstructive pulmonary disease. We present the abstracts (available online) and selected articles from the proceedings of a meeting that took place at the National Institutes of Health (NIH), Bethesda, MD, June 8-10, 2011. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22951901      PMCID: PMC4135376          DOI: 10.1055/s-0031-1301327

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  43 in total

Review 1.  Relative functions of Gαs and its extra-large variant XLαs in the endocrine system.

Authors:  M Bastepe
Journal:  Horm Metab Res       Date:  2012-06-22       Impact factor: 2.936

2.  The high-affinity cAMP-specific phosphodiesterase 8B controls steroidogenesis in the mouse adrenal gland.

Authors:  Li-Chun Lisa Tsai; Masami Shimizu-Albergine; Joseph A Beavo
Journal:  Mol Pharmacol       Date:  2010-12-27       Impact factor: 4.436

3.  PDE4 control on cAMP/PKA compartmentation revealed by biosensor imaging in neurons.

Authors:  P Vincent; L R V Castro; N Gervasi; E Guiot; M Brito; D Paupardin-Tritsch
Journal:  Horm Metab Res       Date:  2012-05-11       Impact factor: 2.936

Review 4.  Acrodysostosis.

Authors:  C Silve; E Clauser; A Linglart
Journal:  Horm Metab Res       Date:  2012-07-19       Impact factor: 2.936

5.  Treating brain tumors with PDE4 inhibitors.

Authors:  Rajarshi Sengupta; Tao Sun; Nicole M Warrington; Joshua B Rubin
Journal:  Trends Pharmacol Sci       Date:  2011-03-28       Impact factor: 14.819

Review 6.  Cyclic nucleotide phosphodiesterase 3 signaling complexes.

Authors:  F Ahmad; E Degerman; V C Manganiello
Journal:  Horm Metab Res       Date:  2012-06-12       Impact factor: 2.936

Review 7.  Protein kinase A alterations in endocrine tumors.

Authors:  B Yu; B Ragazzon; M Rizk-Rabin; J Bertherat
Journal:  Horm Metab Res       Date:  2012-06-29       Impact factor: 2.936

Review 8.  GNAS epigenetic defects and pseudohypoparathyroidism: time for a new classification?

Authors:  G Mantovani; F M Elli; A Spada
Journal:  Horm Metab Res       Date:  2012-06-06       Impact factor: 2.936

9.  Different roles of GNAS and cAMP signaling during early and late stages of osteogenic differentiation.

Authors:  S Zhang; F S Kaplan; E M Shore
Journal:  Horm Metab Res       Date:  2012-08-17       Impact factor: 2.936

Review 10.  Regulation of adrenal steroidogenesis by the high-affinity phosphodiesterase 8 family.

Authors:  L-C L Tsai; J A Beavo
Journal:  Horm Metab Res       Date:  2012-08-17       Impact factor: 2.936

View more
  3 in total

Review 1.  Phosphodiesterase 8B and cyclic AMP signaling in the adrenal cortex.

Authors:  Leticia Ferro Leal; Eva Szarek; Fabio Faucz; Constantine A Stratakis
Journal:  Endocrine       Date:  2015-05-14       Impact factor: 3.633

Review 2.  Phosphodiesterase Inhibitors as a Therapeutic Approach to Neuroprotection and Repair.

Authors:  Eric P Knott; Mazen Assi; Sudheendra N R Rao; Mousumi Ghosh; Damien D Pearse
Journal:  Int J Mol Sci       Date:  2017-03-24       Impact factor: 5.923

3.  A Tissue-Engineered Human Psoriatic Skin Model to Investigate the Implication of cAMP in Psoriasis: Differential Impacts of Cholera Toxin and Isoproterenol on cAMP Levels of the Epidermis.

Authors:  Mélissa Simard; Sophie Morin; Geneviève Rioux; Rachelle Séguin; Estelle Loing; Roxane Pouliot
Journal:  Int J Mol Sci       Date:  2020-07-23       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.